BPC-157 + TB-500 Peptide Blend (5 mg + 5mg and  15mg + 15 mg Strengths)

Research Peptide Combination for Regeneration · Healing · Recovery

BPC-157 + TB-500 is a pharmacist-formulated research peptide blend designed for studies on accelerated healing, tissue repair, and systemic recovery. Each vial contains balanced amounts of two well-known regenerative peptides: BPC-157, a gastric-derived fragment linked to vascular and gut protection, and TB-500, a synthetic fragment of thymosin beta-4 known for its role in cellular migration and wound repair.
GRAM Peptides offers two concentrations—5 mg / 5 mg and 15 mg / 15 mg—to support both standard and high-dose experimental models.

Scientific Overview

BPC-157 + TB-500 provides complementary pathways for tissue regeneration.

• BPC-157 acts on angiogenic and fibroblast growth mechanisms, protecting endothelial tissue and promoting collagen synthesis.
• TB-500 regulates actin binding and cell mobility, enabling faster repair in muscle, tendon, and epithelial models.
  Together, these peptides represent one of the most studied non-hormonal regenerative combinations in preclinical research.

Key Research Applications

Investigators use BPC-157 + TB-500 across multiple study fields:

• Tendon and Ligament Healing – Evaluating post-injury repair and tendon-to-bone integration.
• Muscle Recovery – Assessing regeneration and reduction of inflammation after exertion.
• Vascular and Angiogenic Response – Measuring new-capillary formation and nutrient delivery.
• Neurological and Cellular Repair – Exploring neural regeneration and oxidative-stress modulation.
• Gut and Organ Protection – Testing gastric and hepatic protection mechanisms through BPC-157’s cytoprotective effects.
• Systemic Inflammation Models – Observing cytokine balance and immune-mediated tissue response.

Because each compound influences overlapping but distinct repair pathways, BPC-157 + TB-500 enables researchers to analyze synergy within connective-tissue and vascular regeneration models.

Mechanism of Action

BPC-157 + TB-500 functions through coordinated biological signaling:

• BPC-157 activates angiogenic growth factors (VEGF, FGF), enhances fibroblast proliferation, and stabilizes the gastric mucosa.
• TB-500 regulates actin polymerization and supports endothelial cell migration, critical for wound closure.
• Combined, they enhance collagen deposition, reduce inflammatory mediators, and increase capillary density.

Studies referenced in the National Library of Medicine (PubMed) illustrate how these peptides may accelerate recovery following injury and stress at the cellular level.

Formulation and Strengths

GRAM Peptides manufactures two strengths to meet variable research demands:

• BPC-157 5 mg + TB-500 5 mg – standard concentration suitable for baseline regenerative studies.
• BPC-157 15 mg + TB-500 15 mg – higher-strength formulation for extended or large-model experimentation.

Each vial contains lyophilized powder for sterile reconstitution. All lots are independently tested for purity, identity, and potency.

Why Researchers Choose GRAM Peptides

• Pharmacist-Formulated – Developed by a licensed compounding pharmacist with 20 + years of peptide expertise.
• ISO-Compliant Manufacturing – Produced under controlled clean-room conditions.
• Third-Party Verified – COAs confirm peptide integrity, potency, and purity.
• Transparent Labeling – Every BPC-157 + TB-500 vial is clearly identified by lot and expiration.

GRAM Peptides ensures consistent, research-grade reliability—essential for reproducible results.

Common Research Areas

• Musculoskeletal recovery and tendon repair
• Post-surgical wound healing models
• Angiogenesis and vascular regeneration
• Inflammation and oxidative-stress studies
• Gastrointestinal cytoprotection
• Multi-tissue recovery mechanisms

For related compounds, see our Regeneration & Recovery Collection featuring complementary peptides such as GHK-Cu and KPV.

Frequently Asked Questions

What is BPC-157 + TB-500 used for in research?
It’s evaluated for regenerative, angiogenic, and anti-inflammatory mechanisms in muscle, tendon, and vascular tissues.

Why offer two strengths?
The 5 mg / 5 mg vial supports standard dosing models, while 15 mg / 15 mg allows extended or large-animal studies.

Is BPC-157 + TB-500 FDA-approved?
No. Both peptides are for Research Use Only (RUO) and not approved for human or veterinary treatment.

How is the product supplied?
Each vial contains lyophilized powder ready for sterile reconstitution.

Disclaimer

BPC-157 + TB-500 (5 mg / 15 mg) is sold for Research Use Only (RUO). Not for human consumption, medical, or diagnostic use.